Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tokyo Institute of Technology
Tokyo Institute of Technology
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive